Health

  • December 23, 2025

    'Surprise' Expert Prompts Axing Of $14M Car Crash Verdict

    A California appellate court has vacated a $13.8 million jury verdict after finding that the trial court abused its discretion by allowing a "surprise" medical expert witness to testify at an auto collision trial, saying his testimony likely affected the jury's substantial award.

  • December 23, 2025

    Connecticut's Most Notable Cases Of 2025

    Two attorneys who were licensed in Connecticut were convicted in 2025 on charges that either did or could result in prison time, including a longtime real estate attorney who fatally shot a man in his law firm's parking lot. And the state's largest healthcare system said it would pay $45 million to exit an agreement to buy three ailing hospitals that were in much worse condition than previously known. Here's a look back at three of the top cases of 2025.

  • December 23, 2025

    DHS Finalizes Rule Shifting H-1B Odds To Higher Earners

    The Trump administration finalized changes to the H-1B lottery Tuesday, unveiling a final rule it said will favor higher-paid and higher-skilled positions and tamp down on employers exploiting the program to hire low-wage workers and depress the wages of U.S. workers.

  • December 23, 2025

    Blue Cross Seeks McDonald Hopkins' Fraud Warning Docs

    Advice that McDonald Hopkins LLC gave a Florida hospital manager about potential exposure to criminal prosecution for healthcare fraud is neither privileged nor work product, and so should be handed over to a Blue Cross health insurer being sued for malicious prosecution in Georgia federal court, the insurer said.

  • December 23, 2025

    Sanofi Eczema Drug Linked To Lymphoma, Suit Says

    Drug manufacturers Regeneron Pharmaceuticals and Sanofi were hit with a lawsuit Monday from a Georgia woman alleging the companies have covered up a "strong and consistent causal relationship" between their drug Dupixent and a form of non-Hodgkins lymphoma.

  • December 23, 2025

    Patients Say Pa. Med Mal Firm Left Data Vulnerable To Hackers

    A Pittsburgh law firm that handles medical malpractice and insurance litigation faces a proposed class action complaint alleging that it failed to protect the private health and personal data of patients whose information was stolen in a data breach.

  • December 23, 2025

    11th Circ. Asked To Rehear Pregnancy Center Vandalism Case

    A Florida woman convicted of vandalizing crisis pregnancy centers across the state asked the Eleventh Circuit Monday to reconsider a ruling affirming her conviction, arguing that she should not have been prosecuted under a conspiracy statute for violating the Freedom of Access to Clinic Entrances Act.

  • December 23, 2025

    Johnson & Johnson Hit With $1.5B Talc Verdict In Baltimore

    A Baltimore jury late Monday returned a walloping verdict of more than $1.5 billion in favor of a woman who claimed that Johnson & Johnson talc products caused her mesothelioma, which her attorneys say is the largest verdict against the company for a single plaintiff.

  • December 22, 2025

    Becton Muscles Out Hernia Mesh Rivals, Antitrust Suit Says

    Tela Bio Inc. slapped Becton Dickinson and Co. and its subsidiaries with an antitrust lawsuit Friday in Pennsylvania federal court accusing the medical tech giant of abusing its dominant position in the hernia mesh market to block Tela's product and keep Becton's "costlier and clinically inferior" mesh on hospital shelves in the U.S.

  • December 22, 2025

    Nev. Dental Group Strikes $3.3M Deal In Data Breach Suit

    A Nevada-based dental practice agreed on Friday to pay $3.3 million to resolve proposed class claims over a data breach that potentially affected over 1.2 million people, the plaintiffs said in a request to a federal court for preliminary approval of the deal.

  • December 22, 2025

    Hochul Signs AG James' Bill To Expand Consumer Law

    New York Gov. Kathy Hochul has signed into law New York Attorney General Letitia James' legislation to expand the state's ban on deceptive business practices to also protect against unfair and abusive practices, in the first updates to the state's primary consumer protection law in 45 years.

  • December 22, 2025

    DOJ, SEC Charge 6 In $41M Insider Trading Scheme

    Federal prosecutors in New Jersey have charged six people in connection with what the government is alleging are securities fraud schemes that led to at least $41 million in illicit profits from insider trading, as well as gains from manipulating the stock prices of biopharmaceutical companies.

  • December 22, 2025

    Supreme Court Halts Pittsburgh Post-Gazette Union Order

    The U.S. Supreme Court stayed a Third Circuit order Monday that had required the Pittsburgh Post-Gazette to bargain in good faith with its newsroom workers' union and rescind changes to their healthcare and working conditions, pressing pause on an order that ended a three-year strike at the paper.

  • December 22, 2025

    6th Circ. Vacates Pharma Salesman's $6.8M Restitution Order

    The Sixth Circuit vacated a nearly $7 million restitution order against a pharmaceutical salesman convicted of healthcare fraud, finding an Ohio federal court erred in calculating that amount and apportioning liability.

  • December 22, 2025

    Ed Dept. Ordered To Restore $1B In Mental Health Grants

    The U.S. Department of Education will not be allowed to cut more than $1 billion in mental health grants for schools after a Washington federal judge ruled that the agency acted illegally by citing new, undisclosed Trump administration priorities as a basis for slashing the funding.

  • December 22, 2025

    New Class Action Claims CIBC, RBC Rigged Quantum Shares

    A Quantum Biopharma investor has filed a proposed class action against several major Canadian banks, accusing them of running a spoofing scheme for years that artificially drove down Quantum's stock price — flooding exchanges with fake sell orders to mislead the market and buy shares at deflated prices, costing ordinary shareholders millions.

  • December 19, 2025

    J&J Hit With $66M Verdict In Minnesota Mom's Asbestos Case

    A Minnesota jury Friday awarded a mother of three $65.5 million following a 13-day trial in her lawsuit that claimed Johnson & Johnson's talc products exposed her to asbestos and contributed to cancer in her abdominal lining, the mother's attorneys announced.

  • December 19, 2025

    Feds Fight 'Do-Over' Of Tort Atty's Attempted-Extortion Rap

    Federal prosecutors are urging the Fourth Circuit not to give "a do-over" to a medical malpractice attorney who was convicted of attempting to extort the University of Maryland Medical System out of $25 million and who says his self-representation at trial was not competent.

  • December 19, 2025

    Trump's Cannabis Order: The Impact On Hemp And Research

    President Donald Trump's executive order Thursday reignited an administrative process to reclassify marijuana as a less restricted drug, but its provisions touching on cannabis research and hemp-derived CBD are less obvious.

  • December 19, 2025

    Health Co. CEO Gets 15 Years In $1.4B Fraud Scheme

    A Florida federal judge sentenced a software company CEO to 15 years in prison Friday for participating in a scheme to coordinate illegal medical kickbacks through an internet platform, an operation that resulted in $1.4 billion worth of false billings to Medicare and other insurers for unnecessary medical products.

  • December 19, 2025

    Michigan's 5 Biggest Court Rulings Of 2025

    Michigan courts had a memorable year in 2025, issuing rulings that extended protections against automatic life sentences to young adults, struck down abortion restrictions and pulled the plug on criminal cases related to President Donald Trump's so-called fake elector plot.

  • December 19, 2025

    AstraZeneca Unit Ducks Patent Fraud, Not Sham Suit Claims

    A Massachusetts federal judge spared AstraZeneca unit Alexion on Friday from half of a nonprofit insurer's proposed class action, finding the plaintiff too far removed from anticompetitive patent fraud that allegedly propped up blood disorder treatment Soliris, while preserving accusations that Alexion brought sham infringement allegations against would-be rivals.

  • December 19, 2025

    Squires Issues 21 More Patent Review Denials

    U.S. Patent and Trademark Office Director John Squires has denied 21 requests for America Invents Act patent reviews, while not agreeing to institute any new proceedings.

  • December 19, 2025

    Medical, School Groups Seek Order Halting $100K Visa Fee

    A medical practice in rural North Carolina and other employers asked a federal judge Friday to block enforcement of the Trump administration's $100,000 fee on H-1B visas, arguing the "massive" fee hike will inflict irreparable harm on their communities.

  • December 19, 2025

    Florida Supreme Court To Review Pot Legalization Effort

    The Florida Supreme Court has agreed to weigh whether a new proposal to legalize retail marijuana via ballot initiative complies with the state's constitution.

Expert Analysis

  • Opinion

    Despite Deputy AG Remarks, DOJ Can't Sideline DC Bar

    Author Photo

    Deputy Attorney General Todd Blanche’s recent suggestion that the D.C. Bar would be prevented from reviewing misconduct complaints about U.S. Department of Justice attorneys runs contrary to federal statutes, local rules and decades of case law, and sends the troubling message that federal prosecutors are subject to different rules, say attorneys at HWG.

  • Unique Aspects Of Texas' Approach To AI Regulation

    Author Photo

    The Texas Responsible AI Governance Act — which will soon be the sole comprehensive artificial intelligence law in the U.S. — pulls threads from EU and Colorado laws but introduces more targeted rules with fewer obligations on commercial entities, say attorneys at MVA Law.

  • 3 Takeaways From FDA Cell And Gene Therapy Draft Guidance

    Author Photo

    The U.S. Food and Drug Administration recently published draft guidance documents that sketch the clearest picture yet of the evolving regulatory framework for cell and gene therapies, reflecting an agency that is increasingly comfortable with flexible, science-driven approaches that extend beyond clinical trial models, say attorneys at MoFo.

  • Rule Amendments Pave Path For A Privilege Claim 'Offensive'

    Author Photo

    Litigators should consider leveraging forthcoming amendments to the Federal Rules of Civil Procedure, which will require early negotiations of privilege-related discovery claims, by taking an offensive posture toward privilege logs at the outset of discovery, says David Ben-Meir at Ben-Meir Law.

  • IP Ownership Risk Grows In Booming Cancer Drug Market

    Author Photo

    The ownership of intellectual property has become strategically decisive in deals involving valuable cancer therapeutics known as ADCs, as highlighted by the recent Takeda-Innovent deal, with the commercial value of a license resting on the integrity and defensibility of the underlying technology, say attorneys at Loeb & Loeb.

  • Series

    My Miniature Livestock Farm Makes Me A Better Lawyer

    Author Photo

    Raising miniature livestock on my farm, where I am fully present with the animals, is an almost meditative time that allows me to return to work invigorated, ready to juggle numerous responsibilities and motivated to tackle hard issues in new ways, says Ted Kobus at BakerHostetler.

  • Surveying The Healthcare Policy Landscape Post-Shutdown

    Author Photo

    With last week's agreement to reopen the federal government, at least through the end of January, key healthcare legislation that has been in limbo since a December 2024 spending bill fell apart may recapture the attention of Congress, say attorneys at Faegre Drinker.

  • FDA Biosimilar Guidance Should Ease Biologics Development

    Author Photo

    New draft guidance from the U.S. Food and Drug Administration, indicating that the agency may no longer routinely require comparative efficacy studies when other evidence provides sufficient assurance of biosimilarity, underscores the FDA's trust in analytical technology as a driver of biologics access, say attorneys at Hogan Lovells.

  • Litigation Funding Could Create Ethics Issues For Attorneys

    Author Photo

    A litigation investor’s recent complaint claiming a New York mass torts lawyer effectively ran a Ponzi scheme illustrates how litigation funding arrangements can subject attorneys to legal ethics dilemmas and potential liability, so engagement letters must have very clear terms, says Matthew Feinberg at Goldberg Segalla.

  • E-Discovery Quarterly: Recent Rulings On Dynamic Databases

    Author Photo

    Several recent federal court decisions illustrate how parties continue to grapple with the discovery of data in dynamic databases, so counsel involved in these disputes must consider how structured data should be produced consistent with the requirements of the Federal Rules of Civil Procedure, say attorneys at Sidley.

  • Prison Body Cams Raise Health Privacy Compliance Issues

    Author Photo

    The increasing use of prison staff body cameras to enhance transparency and safety presents correctional healthcare partners with new risk management questions where they must carefully reconcile the benefits of surveillance with the imperative to protect patient privacy, say attorneys at Gordon Rees.

  • Series

    Building With Lego Makes Me A Better Lawyer

    Author Photo

    Building with Lego has taught me to follow directions and adapt to unexpected challenges, and in pairing discipline with imagination, allows me to stay grounded while finding new ways to make complex deals come together, says Paul Levin at Venable.

  • Series

    Law School's Missed Lessons: Networking 101

    Author Photo

    Cultivating a network isn't part of the law school curriculum, but learning the soft skills needed to do so may be the key to establishing a solid professional reputation, nurturing client relationships and building business, says Sharon Crane at Practising Law Institute.

  • Defeating Estoppel-Based Claims In Legal Malpractice Actions

    Author Photo

    State supreme court cases from recent years have addressed whether positions taken by attorneys in an underlying lawsuit can be used against them in a subsequent legal malpractice action, providing a foundation to defeat ex-clients’ estoppel claims, says Christopher Blazejewski at Sherin and Lodgen.

  • How Cos. Can Prep For Tightened Calif. Data Breach Notices

    Author Photo

    Amid California's recent enactment of S.B. 446, which significantly amends the state's data breach notification laws, companies should review and update their incident response plans by establishing processes to document and support any delayed notification, and ensure the notifications' accuracy, say Mark Krotoski and Alexandria Marx at Pillsbury.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.